These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment. Hirsch EC Ann Neurol; 2000 Apr; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138 [TBL] [Abstract][Full Text] [Related]
11. Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Müller T; Renger K; Kuhn W Arch Neurol; 2004 May; 61(5):657-60. PubMed ID: 15148140 [TBL] [Abstract][Full Text] [Related]
12. Levodopa: effect on cell death and the natural history of Parkinson's disease. Olanow CW Mov Disord; 2015 Jan; 30(1):37-44. PubMed ID: 25502620 [TBL] [Abstract][Full Text] [Related]
13. Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease. Müller T Expert Rev Neurother; 2013 Jun; 13(6):707-18. PubMed ID: 23739007 [TBL] [Abstract][Full Text] [Related]
16. Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Ziv I; Zilkha-Falb R; Offen D; Shirvan A; Barzilai A; Melamed E Mov Disord; 1997 Jan; 12(1):17-23. PubMed ID: 8990049 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437 [TBL] [Abstract][Full Text] [Related]
18. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. Gao HM; Jiang J; Wilson B; Zhang W; Hong JS; Liu B J Neurochem; 2002 Jun; 81(6):1285-97. PubMed ID: 12068076 [TBL] [Abstract][Full Text] [Related]
19. Non-dopaminergic drug treatment of Parkinson's disease. Müller T Expert Opin Pharmacother; 2001 Apr; 2(4):557-72. PubMed ID: 11336607 [TBL] [Abstract][Full Text] [Related]
20. Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson's patients? Qureshi GA; Qureshi AA; Devrajani BR; Chippa MA; Syed SA CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):20-7. PubMed ID: 18289028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]